
Once again, the Danish Medicines Council has come under fire. According to Leo Pharma, the council has used the wrong methods to evaluate its eczema treatment Adtralza, affecting several assessment criteria.
This news was reported by Dagens Pharma, which has seen a letter Leo Pharma Nordic sent to the Danish Medicines Council.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app